Highlights and Quick Summary
- Income after Tax for the quarter ending June 30, 2023 was $-64.9 Million (a 46.88% increase compared to previous quarter)
- Year-over-year quarterly Income after Tax increased by 56.82%
- Annual Income after Tax for 2022 was $-168 Million (a 12.6% increase from previous year)
- Annual Income after Tax for 2021 was $-149 Million (a 151.18% increase from previous year)
- Annual Income after Tax for 2020 was $-59.4 Million (a 300.01% increase from previous year)
- Twelve month Income after Tax ending June 30, 2023 was $-189 Million (a 7.13% increase compared to previous quarter)
- Twelve month trailing Income after Tax increased by 4.55% year-over-year
Trailing Income after Tax for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-189 Million | $-177 Million | $-168 Million | $-181 Million |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income after Tax of Dyne Therapeutics, Inc.
Most recent Income after Taxof DYN including historical data for past 10 years.Interactive Chart of Income after Tax of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Income after Tax for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-64.9 | $-44.19 | – | – | – |
| 2022 | $-38.83 | $-41.39 | $-52.3 | $-35.58 | $-168.1 |
| 2021 | $-51.79 | $-42.58 | $-29.96 | $-24.97 | $-149.29 |
| 2020 | $-28.65 | $-13.92 | $-8.98 | $-7.89 | $-59.44 |
| 2019 | $-5.87 | – | – | – | $-14.86 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology